Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Community awareness, use and preference for pandemic influenza vaccines in Pune, India.

Sundaram N, Purohit V, Schaetti C, Kudale A, Joseph S, Weiss MG.

Hum Vaccin Immunother. 2015;11(10):2376-88. doi: 10.1080/21645515.2015.1062956.

2.

Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing.

Chadha MS, Potdar VA, Saha S, Koul PA, Broor S, Dar L, Chawla-Sarkar M, Biswas D, Gunasekaran P, Abraham AM, Shrikhande S, Jain A, Anukumar B, Lal RB, Mishra AC.

PLoS One. 2015 May 4;10(5):e0124122. doi: 10.1371/journal.pone.0124122. eCollection 2015.

3.

Cultural epidemiology of pandemic influenza in urban and rural Pune, India: a cross-sectional, mixed-methods study.

Sundaram N, Schaetti C, Purohit V, Kudale A, Weiss MG.

BMJ Open. 2014 Dec 8;4(12):e006350. doi: 10.1136/bmjopen-2014-006350.

4.

Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach.

Pelat C, Ferguson NM, White PJ, Reed C, Finelli L, Cauchemez S, Fraser C.

Am J Epidemiol. 2014 Nov 15;180(10):1036-46. doi: 10.1093/aje/kwu213. Epub 2014 Sep 25.

5.

Developing and validating a tablet version of an illness explanatory model interview for a public health survey in Pune, India.

Giduthuri JG, Maire N, Joseph S, Kudale A, Schaetti C, Sundaram N, Schindler C, Weiss MG.

PLoS One. 2014 Sep 18;9(9):e107374. doi: 10.1371/journal.pone.0107374. eCollection 2014.

6.

Clinical differences between influenza A (H1N1) pdm09 & influenza B infections identified through active community surveillance in North India.

Purakayastha DR, Gupta V, Broor S, Sullender W, Fowler K, Widdowson MA, Lal RB, Krishnan A.

Indian J Med Res. 2013 Dec;138(6):962-8.

7.

Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.

Kulkarni PS, Agarkhedkar S, Lalwani S, Bavdekar AR, Jog S, Raut SK, Parulekar V, Agarkhedkar SS, Palkar S, Mangrule S.

Hum Vaccin Immunother. 2014;10(3):566-71. Epub 2014 Jan 9.

8.

Case fatality risk of influenza A (H1N1pdm09): a systematic review.

Wong JY, Kelly H, Ip DK, Wu JT, Leung GM, Cowling BJ.

Epidemiology. 2013 Nov;24(6):830-41. doi: 10.1097/EDE.0b013e3182a67448. Review.

9.

Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region.

McCallum L, Partridge J.

Western Pac Surveill Response J. 2010 Dec 10;1(1):5-11. doi: 10.5365/WPSAR.2010.1.1.008. Print 2010 Oct.

10.

Low Level of Cross-Reactive Antibodies to Pandemic Influenza (H1N1) 2009 Virus in Humans in Pre-Pandemic Period in Maharashtra, India.

Kode SS, Pawar SD, Tandale BV, Parkhi SS, Barde TD, Mishra AC.

Indian J Virol. 2012 Jun;23(1):36-8. doi: 10.1007/s13337-011-0055-y. Epub 2012 Jan 10.

11.

Pandemic Influenza A H1N1 (2009) Virus: Lessons from the Past and Implications for the Future.

Khanna M, Kumar B, Gupta A, Kumar P.

Indian J Virol. 2012 Jun;23(1):12-7. doi: 10.1007/s13337-012-0066-3. Epub 2012 Mar 25.

12.

Burden of seasonal and pandemic influenza-associated hospitalization during and after 2009 A(H1N1)pdm09 pandemic in a rural community in India.

Chadha MS, Hirve S, Dawood FS, Lele P, Deoshatwar A, Sambhudas S, Juvekar S, LaFond KE, Mott JA, Lal RB, Mishra AC.

PLoS One. 2013 May 15;8(5):e55918. doi: 10.1371/journal.pone.0055918. Print 2013.

13.

A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac (®) ) in India.

Kulkarni PS, Raut SK, Dhere RM.

Hum Vaccin Immunother. 2013 Jan;9(1):122-4. doi: 10.4161/hv.22317.

14.

Socioeconomic, cultural and behavioural features of prior and anticipated influenza vaccine uptake in urban and rural Pune district, India: a mixed-methods case study.

Kudale A, Purohit VS, Sundaram N, Schaetti C, Weiss MG.

BMJ Open. 2013 Feb 13;3(2). pii: e002573. doi: 10.1136/bmjopen-2013-002573. Print 2013.

15.

Performance of case definitions used for influenza surveillance among hospitalized patients in a rural area of India.

Hirve S, Chadha M, Lele P, Lafond KE, Deoshatwar A, Sambhudas S, Juvekar S, Mounts A, Dawood F, Lal R, Mishra A.

Bull World Health Organ. 2012 Nov 1;90(11):804-12. doi: 10.2471/BLT.12.108837. Epub 2012 Oct 10.

16.

Clinical Profile and Predictors of Mortality of Severe Pandemic (H1N1) 2009 Virus Infection Needing Intensive Care: A Multi-Centre Prospective Study from South India.

Ramakrishna K, Sampath S, Chacko J, Chacko B, Narahari DL, Veerendra HH, Moorthy M, Krishna B, Chekuri V, Raju RK, Shanmugasundaram D, Pichamuthu K, Abraham AM, Abraham O, Thomas K, Mathews P, Varghese GM, Rupali P, Peter JV.

J Glob Infect Dis. 2012 Jul;4(3):145-52. doi: 10.4103/0974-777X.100569.

17.

Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India.

Tandale BV, Pawar SD, Gurav YK, Parkhi SS, Mishra AC.

Hum Vaccin Immunother. 2013 Jan;9(1):125-7. doi: 10.4161/hv.22421. Epub 2012 Oct 9.

18.

Estimation of the burden of pandemic(H1N1)2009 in developing countries: experience from a tertiary care center in South India.

Moorthy M, Samuel P, Peter JV, Vijayakumar S, Sekhar D, Verghese VP, Agarwal I, Moses PD, Ebenezer K, Abraham OC, Thomas K, Mathews P, Mishra AC, Lal R, Muliyil J, Abraham AM.

PLoS One. 2012;7(9):e41507. doi: 10.1371/journal.pone.0041507. Epub 2012 Sep 5.

20.

Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility.

Mukherjee S, Vipat VC, Mishra AC, Pawar SD, Chakrabarti AK.

Virol J. 2011 Mar 25;8:140. doi: 10.1186/1743-422X-8-140.

Items per page

Supplemental Content

Write to the Help Desk